EFFECT OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS ON ERYTHROPOIETIN CONCENTRATIONS IN HEALTHY-VOLUNTEERS

被引:117
作者
PRATT, MC
LEWISBARNED, NJ
WALKER, RJ
BAILEY, RR
SHAND, BI
LIVESEY, J
机构
[1] CHRISTCHURCH HOSP,DEPT NEPHROL,CHRISTCHURCH,NEW ZEALAND
[2] PRINCESS MARGARET HOSP,DEPT ENDOCRINOL,CHRISTCHURCH,NEW ZEALAND
[3] UNIV OTAGO,DEPT MED,DUNEDIN,NEW ZEALAND
关键词
ERYTHROPOIETIN; RENIN-ANGIOTENSIN SYSTEM; ANGIOTENSIN CONVERTING ENZYME INHIBITORS;
D O I
10.1111/j.1365-2125.1992.tb05644.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The possibility that the ACE inhibitors, enalapril and captopril, may decrease plasma EPO concentrations was studied in a single-blind, cross-over study in 10 healthy volunteers. Plasma EPO concentrations, haemoglobin concentration, red blood cell count, plasma creatinine concentration and mean arterial pressure were measured at baseline and after 28 days treatment with both ACE inhibitors. A significant fall in mean plasma EPO concentration occurred with both ACE inhibitors and returned to baseline after stopping the drugs. It is likely that ACE inhibitors decrease EPO formation, by inhibition of angiotensin-II production. This effect could be important in patients with renal failure, renal transplantation or other chronic conditions with an associated anaemia. Haematological parameters should be monitored in such patients when they are treated with an ACE inhibitor.
引用
收藏
页码:363 / 365
页数:3
相关论文
共 15 条
[1]  
ARTEAGA J, 1990, 11TH INT C NEPFHR TO, pA264
[2]  
DREYLING KW, 1990, 11TH INT C NEPHR TOK, pA160
[3]  
FIKLOCKI C, 1990, KIDNEY INT, V38, P367
[4]   HIGH SERUM ERYTHROPOIETIN LEVELS ARE NORMALIZED DURING TREATMENT OF CONGESTIVE HEART-FAILURE WITH ENALAPRIL [J].
FYHRQUIST, F ;
KARPPINEN, K ;
HONKANEN, T ;
SAIJONMAA, O ;
ROSENLOF, K .
JOURNAL OF INTERNAL MEDICINE, 1989, 226 (04) :257-260
[5]  
GOULD AB, 1973, LAB INVEST, V28, P719
[6]  
GOULD AB, 1980, J LAB CLIN MED, V96, P523
[7]  
GRIFFING GT, 1982, LANCET, V1, P1361
[8]   WORSENING OF ANEMIA INDUCED BY LONG-TERM USE OF CAPTOPRIL IN HEMODIALYSIS-PATIENTS [J].
HIRAKATA, H ;
ONOYAMA, K ;
ISEKI, K ;
KUMAGAI, H ;
FUJIMI, S ;
OMAE, T .
AMERICAN JOURNAL OF NEPHROLOGY, 1984, 4 (06) :355-360
[9]  
HIRAKATA H, CLIN NEPHROL, V26, P27
[10]  
JOHNSTON CI, 1987, TXB RENAL DISEASE, P33